Gene, Cell and Tissue

Published by: Kowsar

R462Q Mutation in Prostate Cancer Specimens

Axel Muendlein 1 , * and Alois H. Lang 2
Authors Information
1 Vorarlberg Institute for Vascular Investigation and Treatment (VIVIT), Feldkirch, Austria
2 Department of Internal Medicine, Academic Teaching Hospital Feldkirch, Feldkirch, Austria
Article information
  • Gene, Cell and Tissue: November 01, 2014, 1 (3); e23730
  • Published Online: November 5, 2014
  • Article Type: Letter
  • Received: September 18, 2014
  • Revised: September 30, 2014
  • Accepted: October 1, 2014
  • DOI: 10.17795/gct-23730

To Cite: Muendlein A, H. Lang A. R462Q Mutation in Prostate Cancer Specimens, Gene Cell Tissue. 2014 ; 1(3):e23730. doi: 10.17795/gct-23730.

Copyright © 2014, Zahedan University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
  • 1. Seidabadi A, Rezatofighi SE, Motamedi H, Rashidi I. R462Q Mutation in Prostate Cancer Specimens. Gene Cell Tissue. 2014; 1(2)
  • 2. Pourmand GR, Allameh F, Mohammad K, Dehghani S, Pourmand B, Mehrsai AR, et al. Prostate cancer predicting factors: a preliminary report from Tehran. Urol J. 2012; 9(4): 667-72[PubMed]
  • 3. Hsing AW, Chokkalingam AP. Prostate cancer epidemiology. Front Biosci. 2006; 11: 1388-413[PubMed]
  • 4. Silverman RH. Implications for RNase L in prostate cancer biology. Biochemistry. 2003; 42(7): 1805-12[DOI][PubMed]
  • 5. Wei B, Xu Z, Ruan J, Zhu M, Jin K, Zhou D, et al. RNASEL Asp541Glu and Arg462Gln polymorphisms in prostate cancer risk: evidences from a meta-analysis. Mol Biol Rep. 2012; 39(3): 2347-53[DOI][PubMed]
  • 6. Kheirandish P, Chinegwundoh F. Ethnic differences in prostate cancer. Br J Cancer. 2011; 105(4): 481-5[DOI][PubMed]
  • 7. Mi Y, Yu Q, Min Z, Xu B, Zhang L, Zhang W, et al. Arg462Gln and Asp541Glu polymorphisms in ribonuclease L and prostate cancer risk: a meta-analysis. J Biomed Res. 2010; 24(5): 365-73[DOI][PubMed]
  • 8. Xiang Y, Wang Z, Murakami J, Plummer S, Klein EA, Carpten JD, et al. Effects of RNase L mutations associated with prostate cancer on apoptosis induced by 2',5'-oligoadenylates. Cancer Res. 2003; 63(20): 6795-801[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .
Readers' Comments